Do you want to read an article? Please log in or register.
Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial
Retinal DiseasesFurther Publications
Related content
RECOMMENDED
Further Publications
Efficacy and Safety of Different Atropine Regimens for the Treatment of Myopia in Children: Three-Year Results of the MOSAIC Randomized Clinical Trial
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
JAMA Ophthalmol
Loughman J, Lingham G, Nkansah EK, Kobia-Acquah E, Flitcroft DI
doi: 10.1001/jamaophthalmol.2024.5703
Dry Eye Disease
Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trial
BMC Ophthalmol
Donnenfeld E, Coats J, Barbour K, Ryan R, Joshi NR, Periman LM
doi: 10.1186/s12886-024-03688-z
Macular Diseases
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-related Macular Degeneration: A Phase 3 Randomized Trial
Ophthalmol Retina
Hamouz J, Nowosielska A, Święch-Zubilewicz A, Abengoechea S, Baumane K, Vajas A, Siewierska M, Veselovsky M, Veith M, Kerényi Á, Mange S, Baidya K, Laganovska G, Jürgens I, Papp A, Gosai J, Štefanickova J, Han M, Fryczkowski P, Zalewski D, Wang J, Wei W
doi: 10.1016/j.oret.2024.10.001
Macular DiseasesRetinal Diseases
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial
JAMA Ophthalmol
Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P
doi: 10.1001/jamaophthalmol.2025.0001
Retinal Diseases
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
BMC Ophthalmol
Zhong Y, Lin X, Yang Y, He L, Li N, Lu J, Zhou Y, Zhang R, Wang Y, Zhang Z, Yang M, Yin H, Zhao M, Li X, Liang J, Cheng Y
doi: 10.1186/s12886-024-03836-5
Uveitis
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial
JAMA Ophthalmol
Srivastava SK, Watkins TR, Nguyen QD, Sharma S, Scales DK, Dacey MS, Shah RE, Chu DS, Grewal DS, Faia LJ, Suhler EB, Genovese MC, Guo Y, Barchuk WT, Besuyen R, Dick AD, Rosenbaum JT
doi: 10.1001/jamaophthalmol.2024.2439
Further Publications
Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial
JAMA Ophthalmol
Cohen EJ, Troxel AB, Liu M, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Warner DB, Lu Y, Twi-Yeboah A, Lee TF, Kim J, Lopez-Jimenez C, Laury SC, Jeng BH, ZEDS Trial Research Group
doi: 10.1001/jamaophthalmol.2024.6114
Further Publications
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial
JAMA Ophthalmol
Warner DB, Jeng BH, Kim J, Liu M, Troxel AB, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Meyer JJ, Lu Y, Twi-Yeboah A, Lee TF, Lopez-Jimenez C, Laury SC, Cohen EJ, ZEDS Trial Research Group
doi: 10.1001/jamaophthalmol.2024.6113
Macular Diseases
Tissue Plasminogen Activator or Perfluoropropane for Submacular Hemorrhage in Age-Related Macular Degeneration: A Factorial Randomized Clinical Trial
JAMA Ophthalmol
Murphy GSP, Saleh A, Ayis S, Cheema MR, Mehta A, Steel DH, Membrey L, Costen M, Jackson TL
doi: 10.1001/jamaophthalmol.2024.4297